Search Result For: CB1 receptor

Date: 2025/06/07 - 05:00

GLP-1 Drugs Linked to Age-Related Macular Degeneration, Study Finds

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the longer people were prescribed a GLP-1 drug, particularly those containing semaglutide.

Psilocybin mushrooms, commonly known as magic mushrooms, growing out of a stub

Date: 2025/06/06 - 20:00

Could psilocybin help treat IBS? A new study investigates

The first clinical trial examining the effects of psilocybin, the compound in magic mushrooms, on treatment-resistant IBS suggests altering the mind may be key to helping the gut.

two white pills on person's outstretched palm

Date: 2025/06/04 - 20:31

Could a sleeping pill help prevent toxic tau buildup in the brain?

Lemborexant, a medication commonly used to treat insomnia, may help protect the brain from tau buildup, a marker of Alzheimer's progression, a mouse study suggests.

Date: 2025/05/29 - 22:30

NIH scientists pioneer promising treatment for intractable cancer pain

RTX is a non-addictive pain therapy derived from a cactus-like plant.

Date: 2025/05/22 - 20:00

NIH scientists test in an animal model a surgical technique to improve cell therapy for dry AMD

The technique may enable higher doses and combinations of cell therapies.

Date: 2025/05/19 - 22:32

Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.

Date: 2025/05/15 - 23:32

FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.

Date: 2025/05/13 - 23:32

First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.

Two syringes of Ozempic and Wegovy, the active ingredient of which is semaglutide, are seen side by side, half illuminated by sunlight

Date: 2025/05/13 - 16:00

Diabetes and weight loss drug semaglutide may also treat liver disease

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a serious form of fatty liver disease, a new study has found.

Date: 2025/05/07 - 00:31

Mounjaro supports consistent weight loss, long-term data confirm

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with overweight or obesity who do not have diabetes.